ELUT
ELUT
NASDAQ · Biotechnology

Elutia Inc

$0.98
+0.02 (+2.42%)
As of Jun 30, 10:42 PM ET ·
Financial Highlights (FY 2026)
Revenue
12.77M
Net Income
55.43M
Gross Margin
53.7%
Profit Margin
434.2%
Rev Growth
-37.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 53.7% 53.7% 61.3% 61.3%
Operating Margin -218.9% -197.0% 22.2% 22.8%
Profit Margin 434.2% 412.5% 23.2% 18.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 12.77M 20.27M 7.77M 7.02M
Gross Profit 6.85M 10.87M 4.76M 4.31M
Operating Income -27,945,446 -39,928,403 1.72M 1.61M
Net Income 55.43M 79.20M 1.80M 1.31M
Gross Margin 53.7% 53.7% 61.3% 61.3%
Operating Margin -218.9% -197.0% 22.2% 22.8%
Profit Margin 434.2% 412.5% 23.2% 18.7%
Rev Growth -37.0% -37.0% +3.8% -2.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 19.50M 20.13M
Total Equity 23.16M 25.61M
D/E Ratio 0.84 0.79
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -25,054,024 -37,785,875 2.38M 2.09M
Free Cash Flow 1.78M 1.31M